唑吡坦 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "唑吡坦" in Chinese language version.

refsWebsite

Global rank Chinese rank

10nih.gov

4^th place

5^th place

9doi.org

2^nd place

23^rd place

8web.archive.org

1^st place

5semanticscholar.org

11^th place

332^nd place

1ambien.com

low place

1sanofi-aventis.com.au

low place

1sanofi-aventis.com

low place

1non-benzodiazepines.org.uk

low place

1harvard.edu

18^th place

57^th place

1springer.de

low place

1aspetjournals.org

6,663^rd place

8,533^rd place

1archive.org

6^th place

4^th place

1drugs.com

399^th place

208^th place

1sanofi.cn

low place

ambien.com

Ambien.com. AMBIEN Prescribing Information. Information About a Short-term Treatment for Insomnia - Ambien.com Home Page for Health-care Professionals. Sanofi-Synthelabo Inc. New York, NY 10016. 2004 [2005-06-27]. （原始内容存档于2005-06-27）.

archive.org

Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Human Psychopharmacology. July 2004, 19 (5): 305–22. PMID 15252823. S2CID 10888200. doi:10.1002/hup.594.

aspetjournals.org

molpharm.aspetjournals.org

Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ. Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit. Molecular Pharmacology. September 1996, 50 (3): 670–8 [7 October 2007]. PMID 8794909. （原始内容存档于8 January 2009）.

doi.org

Salvà P, Costa J. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clinical Pharmacokinetics. September 1995, 29 (3): 142–153. PMID 8521677. S2CID 23391285. doi:10.2165/00003088-199529030-00002.
Che Has AT, Absalom N, van Nieuwenhuijzen PS, Clarkson AN, Ahring PK, Chebib M. Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface. Scientific Reports. June 2016, 6: 28674. Bibcode:2016NatSR...628674C. PMC 4921915 . PMID 27346730. doi:10.1038/srep28674.
Pritchett DB, Seeburg PH. Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology. Journal of Neurochemistry. May 1990, 54 (5): 1802–4. PMID 2157817. S2CID 86674799. doi:10.1111/j.1471-4159.1990.tb01237.x.
Smith AJ, Alder L, Silk J, Adkins C, Fletcher AE, Scales T, Kerby J, Marshall G, Wafford KA, McKernan RM, Atack JR. Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux. Molecular Pharmacology. May 2001, 59 (5): 1108–18. PMID 11306694. S2CID 86156878. doi:10.1124/mol.59.5.1108.
Rowlett JK, Woolverton WL. Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies. Psychopharmacology. November 1996, 128 (1): 1–16. PMID 8944400. S2CID 25654504. doi:10.1007/s002130050103. （原始内容存档于12 January 2002）.
Perrais D, Ropert N. Effect of zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses. The Journal of Neuroscience. January 1999, 19 (2): 578–88. PMC 6782193 . PMID 9880578. doi:10.1523/JNEUROSCI.19-02-00578.1999.
Noguchi H, Kitazumi K, Mori M, Shiba T. Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats. Journal of Pharmacological Sciences. March 2004, 94 (3): 246–51. PMID 15037809. doi:10.1254/jphs.94.246 . WARNING: The reference indicates that zaleplon-Sonata, not zolpidem, increases Slow-wave sleep
Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Human Psychopharmacology. July 2004, 19 (5): 305–22. PMID 15252823. S2CID 10888200. doi:10.1002/hup.594.
Von Moltke LL, Greenblatt DJ, Granda BW, Duan SX, Grassi JM, Venkatakrishnan K, et al. Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. British Journal of Clinical Pharmacology. July 1999, 48 (1): 89–97. PMC 2014868 . PMID 10383565. doi:10.1046/j.1365-2125.1999.00953.x.

drugs.com

Zolpidem (Monograph). The American Society of Health-System Pharmacists. 27 April 2023 [10 March 2024]. （原始内容存档于2018-03-16）.

harvard.edu

ui.adsabs.harvard.edu

Che Has AT, Absalom N, van Nieuwenhuijzen PS, Clarkson AN, Ahring PK, Chebib M. Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface. Scientific Reports. June 2016, 6: 28674. Bibcode:2016NatSR...628674C. PMC 4921915 . PMID 27346730. doi:10.1038/srep28674.

nih.gov

ncbi.nlm.nih.gov

Salvà P, Costa J. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clinical Pharmacokinetics. September 1995, 29 (3): 142–153. PMID 8521677. S2CID 23391285. doi:10.2165/00003088-199529030-00002.
Che Has AT, Absalom N, van Nieuwenhuijzen PS, Clarkson AN, Ahring PK, Chebib M. Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface. Scientific Reports. June 2016, 6: 28674. Bibcode:2016NatSR...628674C. PMC 4921915 . PMID 27346730. doi:10.1038/srep28674.
Pritchett DB, Seeburg PH. Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology. Journal of Neurochemistry. May 1990, 54 (5): 1802–4. PMID 2157817. S2CID 86674799. doi:10.1111/j.1471-4159.1990.tb01237.x.
Smith AJ, Alder L, Silk J, Adkins C, Fletcher AE, Scales T, Kerby J, Marshall G, Wafford KA, McKernan RM, Atack JR. Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux. Molecular Pharmacology. May 2001, 59 (5): 1108–18. PMID 11306694. S2CID 86156878. doi:10.1124/mol.59.5.1108.
Rowlett JK, Woolverton WL. Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies. Psychopharmacology. November 1996, 128 (1): 1–16. PMID 8944400. S2CID 25654504. doi:10.1007/s002130050103. （原始内容存档于12 January 2002）.
Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ. Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit. Molecular Pharmacology. September 1996, 50 (3): 670–8 [7 October 2007]. PMID 8794909. （原始内容存档于8 January 2009）.
Perrais D, Ropert N. Effect of zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses. The Journal of Neuroscience. January 1999, 19 (2): 578–88. PMC 6782193 . PMID 9880578. doi:10.1523/JNEUROSCI.19-02-00578.1999.
Noguchi H, Kitazumi K, Mori M, Shiba T. Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats. Journal of Pharmacological Sciences. March 2004, 94 (3): 246–51. PMID 15037809. doi:10.1254/jphs.94.246 . WARNING: The reference indicates that zaleplon-Sonata, not zolpidem, increases Slow-wave sleep
Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Human Psychopharmacology. July 2004, 19 (5): 305–22. PMID 15252823. S2CID 10888200. doi:10.1002/hup.594.
Von Moltke LL, Greenblatt DJ, Granda BW, Duan SX, Grassi JM, Venkatakrishnan K, et al. Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations. British Journal of Clinical Pharmacology. July 1999, 48 (1): 89–97. PMC 2014868 . PMID 10383565. doi:10.1046/j.1365-2125.1999.00953.x.

non-benzodiazepines.org.uk

Benzodiazepine Names. （原始内容存档于2008-12-08）.

sanofi-aventis.com

en.sanofi-aventis.com

sanofi-aventis : Drugs and Products - CNS - Stilnox/Ambien/Myslee. 2006-11-07 [2006-11-22]. （原始内容存档于2007-09-27）.

sanofi-aventis.com.au

STILNOX (zolpidem tartrate) PRODUCT INFORMATION （页面存档备份，存于互联网档案馆） Sanofi-Synthelabo Australia Pty Limited. April 15, 2004

sanofi.cn

酒石酸唑吡坦说明书 (PDF). [2024-07-07]. （原始内容存档 (PDF)于2024-07-07）（中文）.

semanticscholar.org

api.semanticscholar.org

Salvà P, Costa J. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clinical Pharmacokinetics. September 1995, 29 (3): 142–153. PMID 8521677. S2CID 23391285. doi:10.2165/00003088-199529030-00002.
Pritchett DB, Seeburg PH. Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology. Journal of Neurochemistry. May 1990, 54 (5): 1802–4. PMID 2157817. S2CID 86674799. doi:10.1111/j.1471-4159.1990.tb01237.x.
Smith AJ, Alder L, Silk J, Adkins C, Fletcher AE, Scales T, Kerby J, Marshall G, Wafford KA, McKernan RM, Atack JR. Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux. Molecular Pharmacology. May 2001, 59 (5): 1108–18. PMID 11306694. S2CID 86156878. doi:10.1124/mol.59.5.1108.
Rowlett JK, Woolverton WL. Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies. Psychopharmacology. November 1996, 128 (1): 1–16. PMID 8944400. S2CID 25654504. doi:10.1007/s002130050103. （原始内容存档于12 January 2002）.
Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Human Psychopharmacology. July 2004, 19 (5): 305–22. PMID 15252823. S2CID 10888200. doi:10.1002/hup.594.

springer.de

link.springer.de

Rowlett JK, Woolverton WL. Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies. Psychopharmacology. November 1996, 128 (1): 1–16. PMID 8944400. S2CID 25654504. doi:10.1007/s002130050103. （原始内容存档于12 January 2002）.

web.archive.org

Ambien.com. AMBIEN Prescribing Information. Information About a Short-term Treatment for Insomnia - Ambien.com Home Page for Health-care Professionals. Sanofi-Synthelabo Inc. New York, NY 10016. 2004 [2005-06-27]. （原始内容存档于2005-06-27）.
STILNOX (zolpidem tartrate) PRODUCT INFORMATION （页面存档备份，存于互联网档案馆） Sanofi-Synthelabo Australia Pty Limited. April 15, 2004
sanofi-aventis : Drugs and Products - CNS - Stilnox/Ambien/Myslee. 2006-11-07 [2006-11-22]. （原始内容存档于2007-09-27）.
Benzodiazepine Names. （原始内容存档于2008-12-08）.
Rowlett JK, Woolverton WL. Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies. Psychopharmacology. November 1996, 128 (1): 1–16. PMID 8944400. S2CID 25654504. doi:10.1007/s002130050103. （原始内容存档于12 January 2002）.
Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ. Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit. Molecular Pharmacology. September 1996, 50 (3): 670–8 [7 October 2007]. PMID 8794909. （原始内容存档于8 January 2009）.
Zolpidem (Monograph). The American Society of Health-System Pharmacists. 27 April 2023 [10 March 2024]. （原始内容存档于2018-03-16）.
酒石酸唑吡坦说明书 (PDF). [2024-07-07]. （原始内容存档 (PDF)于2024-07-07）（中文）.